Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interleukin 2 therapy in severe atopic dermatitis.

K H Hsieh1, C C Chou, S F Huang

  • 1Department of Pediatrics, National Taiwan University Hospital, Taipei, Republic of China.

Journal of Clinical Immunology
|January 1, 1991
PubMed
Summary

Interleukin 2 (IL-2) therapy temporarily improved severe atopic dermatitis (AD) by reducing T-cells. Symptoms recurred after treatment cessation, suggesting IL-2

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Establishment of feline in-house reference intervals for hematologic and biochemical parameters and potential age-related differences.

Polish journal of veterinary sciences·2019
Same author

Influence of Potassium Sorbate on the Growth of Yersinia enterocolitica.

Journal of food protection·2019
Same author

Plasma indoxyl sulfate concentration predicts progression of chronic kidney disease in dogs and cats.

Veterinary journal (London, England : 1997)·2018
Same author

Plasma pharmacokinetics and tissue depletion of cyromazine and its metabolite melamine following oral administration in laying chickens.

Journal of veterinary pharmacology and therapeutics·2016
Same author

Detection of indoxyl sulfate levels in dogs and cats suffering from naturally occurring kidney diseases.

Veterinary journal (London, England : 1997)·2015
Same author

Associations between serum total bilirubin levels and functional dependence in the elderly.

Internal medicine journal·2011

Area of Science:

  • Immunology
  • Dermatology

Background:

  • Severe atopic dermatitis (AD) often proves refractory to conventional treatments.
  • Interleukin 2 (IL-2) is a cytokine involved in immune responses.

Purpose of the Study:

  • To evaluate the efficacy and immunological effects of Interleukin 2 (IL-2) in patients with severe atopic dermatitis (AD).

Main Methods:

  • Six patients with severe AD received IL-2 (10,000–20,000 U/kg every 8 hours) for 9–12 days.
  • Clinical assessments, laboratory tests (including T-cell subsets, serum IgE), and skin biopsies were performed.

Main Results:

  • IL-2 therapy led to significant improvement in eczema symptoms like pruritus and lichenification.
  • Recurrence of symptoms was observed 2–6 weeks after discontinuing IL-2.
  • Skin biopsies revealed decreased CD4+ T-cells and increased CD25 expression, suggesting modulation of immune cell activity.

Conclusions:

  • IL-2 demonstrates transient efficacy in severe AD, likely through depletion of helper/inducer CD4+ T-cells.
  • This mechanism may abrogate exaggerated antigen processing and cellular activation in affected skin.

Related Experiment Videos